Pruebas
Malignant Cell Count
The determination of the number of malignant cells present in a sample.
Loading
Loading
Busque productos, empresas, pruebas y guías: pase de la consulta a la solicitud de cotización en un solo lugar.
Pruebas
The determination of the number of malignant cells present in a sample.
Indicadores
An antigen expressed by tissues derived from mullerian epithelium (tubal, endometrial and endocervical) or celomic epithelium (mesothelial cells of the pleura, pericardium and peritoneum). Although its biochemical nature has not been clearly defined, CA125 has been described as a glycosylated, high-molecular-weight protein that may be released from damaged cells. Measurable in plasma, CA125 is a sensitive, nonspecific tumor marker for ovarian cancer; as such it is much more useful for monitoring clinical responses to the treatment of ovarian cancer than for the diagnosis of ovarian cancer. Elevated plasma CA125 may occur in association with other malignancies and non-malignant gynecologic disorders. (NCI04)
Artículo
Research record from Front Cell Infect Microbiol, 2026-07-27. PMID 42577578.
Artículo
Research record from Int J Infect Dis, 2026-03-30. PMID 41921901.
Artículo
Research record from Cancer Cytopathol, 2026-05-01. PMID 42046206.
Artículo
Research record from Turk J Haematol, 2026-05-13. PMID 42126222.
Pruebas
The determination of the ratio of malignant cells compared to blood cells present in a sample. The measurement may be expressed as a ratio or percentage.
Artículo
Research record from IDCases, 2026-05-25. PMID 42253890.